Which statement best describes varenicline's overall approach to smoking cessation?

• A. Reduces cravings by partial receptor activation and dopamine release
• B. Increases nicotine uptake to reduce withdrawal
• C. Blocks nicotine metabolism leading to reduced blood nicotine levels
• D. Acts as a pure nicotine substitute

Answer: (A)

Varenicline works by binding to the alpha4beta2 nicotinic acetylcholine receptors in the brain as a partial agonist. This means it activates the receptor just enough to ease withdrawal and reduce cravings, while also occupying the receptor so nicotine can’t produce the same strong dopamine release that reinforces smoking. In this way, it provides a controlled dopamine boost that helps curb urges without delivering nicotine’s full rewarding effects. The result aligns with the statement that cravings are reduced through partial receptor activation and dopamine release. It’s not about increasing nicotine uptake, blocking nicotine metabolism, or acting as a pure nicotine substitute.